当前位置:首页 - 行情中心 - 神奇制药(600613) - 财务分析 - 现金流量表

神奇制药

(600613)

  

流通市值:26.55亿  总市值:29.59亿
流通股本:4.79亿   总股本:5.34亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金398,484,909.641,761,489,997.181,257,942,651.43898,673,389.76
  收到的税费返还987.241,803,052.271,803,052.271,800,723.27
  收到其他与经营活动有关的现金13,015,054.8970,121,787.11149,894,059.54120,444,500.44
  经营活动现金流入小计411,500,951.771,833,414,836.561,409,639,763.241,020,918,613.47
  购买商品、接受劳务支付的现金165,268,311.68655,673,677.44473,860,693.71429,382,273.84
  支付给职工以及为职工支付的现金51,654,253.01189,128,664.46142,613,896.0797,820,299.76
  支付的各项税费39,409,342.43183,410,402.14115,228,805.1980,956,146.07
  支付其他与经营活动有关的现金114,631,209.2680,728,957.02520,628,610.93365,285,779.2
  经营活动现金流出小计370,963,116.321,708,941,701.061,252,332,005.9973,444,498.87
  经营活动产生的现金流量净额40,537,835.45124,473,135.5157,307,757.3447,474,114.6
二、投资活动产生的现金流量:
  收回投资收到的现金100,000,000160,000,00060,000,00020,000,000
  取得投资收益收到的现金1,034,451.382,870,801.91974,897.56974,897.56
  处置固定资产、无形资产和其他长期资产收回的现金净额-173.8555,807.05222,445.418,700
  收到的其他与投资活动有关的现金--212,618.78-
  投资活动现金流入小计101,034,277.53162,926,608.9661,409,961.7520,983,597.56
  购建固定资产、无形资产和其他长期资产支付的现金3,746,939.9533,215,442.7524,648,331.8117,657,323.92
  投资支付的现金141,580,000330,000,000250,000,00040,000,000
  投资活动现金流出小计145,326,939.95363,215,442.75274,648,331.8157,657,323.92
  投资活动产生的现金流量净额-44,292,662.42-200,288,833.79-213,238,370.06-36,673,726.36
三、筹资活动产生的现金流量:
  取得借款收到的现金30,000,00061,877,258.3428,222,00028,222,000
  筹资活动现金流入小计30,000,00061,877,258.3428,222,00028,222,000
  偿还债务支付的现金133,302,00070,520,00043,496,922.2243,496,922.22
  分配股利、利润或偿付利息支付的现金1,784,902.6688,544,755.8786,744,039.4885,212,315.56
  其中:子公司支付给少数股东的股利、利润160,000320,000--
  支付其他与筹资活动有关的现金2,862,301.212,272,915.1110,362,318.28,168,022.6
  筹资活动现金流出小计137,949,203.86171,337,670.98140,603,279.9136,877,260.38
  筹资活动产生的现金流量净额-107,949,203.86-109,460,412.64-112,381,279.9-108,655,260.38
四、汇率变动对现金及现金等价物的影响-17,032.25-25,110.535,907.15-5,907.15
五、现金及现金等价物净增加额-111,721,063.08-185,301,221.46-168,305,985.47-97,860,779.29
  加:期初现金及现金等价物余额594,091,354.93779,392,576.39779,392,576.39779,392,576.39
  期末现金及现金等价物余额482,370,291.85594,091,354.93611,086,590.92681,531,797.1
补充资料:
  净利润-39,835,084.74-34,414,505.45
  资产减值准备-21,264,639.42-8,017,259.23
  固定资产和投资性房地产折旧-71,168,609.73-33,492,761.59
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-71,168,609.73-33,492,761.59
  无形资产摊销-3,429,609.65-1,039,763.7
  长期待摊费用摊销-1,072,905.29-577,775.28
  处置固定资产、无形资产和其他长期资产的损失--227,956.19--
  固定资产报废损失-11,576.13--
  公允价值变动损失--548,844.96--151,126.36
  财务费用-9,373,484.93-5,902,314.9
  投资损失--2,994,678.83--
  递延所得税--1,196,911.97--14,925
  其中:递延所得税资产减少--1,773,909.74-1,255,371.4
    递延所得税负债增加-576,997.77--1,270,296.4
  存货的减少-14,496,662.74-26,237,377.84
  经营性应收项目的减少-8,935,230.51-34,435,195.2
  经营性应付项目的增加--68,877,389.46--111,401,538.21
  现金的期末余额-594,091,354.93-681,531,797.1
  减:现金的期初余额-779,392,576.39-779,392,576.39
  现金及现金等价物的净增加额--185,301,221.46--97,860,779.29
公告日期2026-04-292026-04-292025-10-312025-08-30
审计意见(境内)标准无保留意见
TOP↑